Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling

Over the last 20 years, the efforts to develop new therapies for Parkinson’s disease (PD) have focused not only on the improvement of symptomatic therapy for motor and non-motor symptoms but also on the discovering of the potential causes of PD, in order to develop disease-modifying treatments. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovannini, Daniela, Andreola, Federica, Spitalieri, Paola, Krasnowska, Ewa Krystyna, Colini Baldeschi, Arianna, Rossi, Simona, Sangiuolo, Federica, Cozzolino, Mauro, Serafino, Annalucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560781/
https://www.ncbi.nlm.nih.gov/pubmed/34725335
http://dx.doi.org/10.1038/s41420-021-00723-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560781/
https://www.ncbi.nlm.nih.gov/pubmed/34725335
http://dx.doi.org/10.1038/s41420-021-00723-6

Ejemplares similares